Clinical trial
Risk-Based 6MP Adherence Enhancement Strategies in Children, Adolescent and Young Adults With ALL - A Pilot Study
NCT06639958 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk-Based 6MP Adherence Enhancement Strategies in Children, Adolescent and Young Adults With ALL - A Pilot Study
- Lead sponsor
- Children's Oncology Group
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- December 4, 2024
- Completion date
- March 3, 2027
- Enrollment
- 64 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, childhood acute lymphoblastic leukemia